OOIR: Observatory of International Research

Papers

(The TQCC of Annual Review of Medicine is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The Gut–Brain Axis	268
Phage Therapy for Antibiotic-Resistant Bacterial Infections	244
mRNA Vaccines in the COVID-19 Pandemic and Beyond	146
Hepcidin and Iron in Health and Disease	118
The Role of Exercise in Management of Mental Health Disorders: An Integrative Review	112
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment	111
The Gut Microbiome and Inflammatory Bowel Diseases	108
Hepatocellular Carcinoma Immunotherapy	104
Engineering IL-2 to Give New Life to T Cell Immunotherapy	80
Cardiovascular Effects of Particulate Air Pollution	79
New Therapeutics for Ulcerative Colitis	73
Diagnosis and Treatment of Helicobacter pylori Infection	72
Post-COVID-19 Condition	71
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines	69
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches	68
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies	65
COVID-19 and Diabetes	65
Direct-to-Consumer Genetic Testing: Value and Risk	56
Clinical Perspectives on IgG4-Related Disease and Its Classification	55
COVID-19: Challenges of Viral Variants	55
Hematopoietic Stem Cell Transplantation for Autoimmune Disease	55
Advances in Chronic Obstructive Pulmonary Disease	54
COVID-19: Inflammatory Profile	52
Synchronizing Brain Rhythms to Improve Cognition	50
Cytokine Storm Syndrome	49

New Therapeutics for Hepatitis B: The Road to Cure	48
COVID-19 Vaccines: Adenoviral Vectors	44
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression	44
Contemporary Management of Thyroid Nodules	44
Wearable Devices to Monitor and Reduce the Risk of Cardiovascular Disease: Evidence and Opportunities	43
Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches	43
Therapeutics Targeting Mutant KRAS	43
Adeno-Associated Virus Gene Therapy for Hemophilia	42
Aspirin in the Prevention of Colorectal Neoplasia	42
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone	40
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy	40